Direkt zum Inhalt
Merck
  • [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].

[How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].

Revue medicale de Liege (2006-05-10)
F Henry, C Flagothier, C Piérard-Franchimont, G E Piérard
ZUSAMMENFASSUNG

The combination of calcipotriol and betamethasone dipropionate in a single topical formulation is a recent advance in treatment of plaque type psoriasis. Studies rooted on evidence-based medicine have been recently published. We report a synthesis and a critical analysis, critical analysis of these investigations, and translate their data with a view to apply them in daily practice.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Betamethason, ≥98%
USP
Betamethasondipropionat, United States Pharmacopeia (USP) Reference Standard
Supelco
Betamethasondipropionat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Betamethason, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Betamethason-17,21-Dipropionat
Supelco
Betamethason, VETRANAL®, analytical standard
Betamethason, European Pharmacopoeia (EP) Reference Standard
Betamethasondipropionat, European Pharmacopoeia (EP) Reference Standard
Betamethasondipropionat für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard